Engineers Gate Manager LP Iovance Biotherapeutics, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $101,711 - $201,361	22,908 New	22,908 $104,000
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $52,977 - $78,747	-9,580 Reduced 46.69%	10,940 $66,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $58,700 - $104,450	-10,445 Reduced 33.73%	20,520 $131,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $174,551 - $240,122	18,316 Added 144.8%	30,965 $297,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $80,700 - $231,856	12,649 New	12,649 $140,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.